학술논문

Using metabolomic and transcriptomic profiles to predict development of anti-drug antibodies in people with relapsing remitting multiple sclerosis
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; OCT 2022, 28 3_SUPPL, p303-p304, 2p. Supplement: 3_
Subject
Language
English
ISSN
14770970